Liver Health Journey: From ALT to MRI

Your blood test came back with raised ALT. Now what? This guide walks you through the entire liver health pathway — from understanding what that first abnormal result means, through the investigation process, to what a liver MRI can tell you that blood tests can't. Think of it as a step-by-step map from "your ALT is raised" to "here's exactly what's going on with your liver."

Step 1: The Initial Blood Test

Most liver investigations start the same way — a routine blood test flags raised ALT. Here's how to read the initial results:

The Key Liver Markers

Marker Normal Range What Elevation Means
ALT 7–56 U/L Liver cell damage (most specific marker)
AST 10–40 U/L Liver, heart, or muscle damage
GGT 9–48 U/L Alcohol, bile duct issues
ALP 44–147 U/L Bile duct or bone disease
Bilirubin 3–17 µmol/L Liver processing or bile flow
Albumin 35–50 g/L Liver synthetic function (low = chronic damage)

Reading the Pattern

  • ALT raised, AST normal or lower than ALT: Most common pattern. Usually NAFLD (non-alcoholic fatty liver disease) or medication effect.
  • AST higher than ALT (ratio >2:1): Suggests alcohol-related liver damage.
  • GGT + ALP raised, ALT normal: Points to bile duct obstruction — consider MRCP imaging.
  • Everything raised: Significant liver disease — needs prompt investigation.
  • Low albumin: Suggests chronic liver damage (the liver is struggling to make proteins).

Start with a Blood Test — Peak 70 Panel

70 biomarkers covering liver, kidney, thyroid, hormones, inflammation, and more. Results in 2 working days.

View Blood Test Details →

Step 2: Rule Out Common Causes

Before jumping to imaging, your GP should check for reversible causes:

  • Medications: Statins, paracetamol (chronic use), antibiotics, NSAIDs — can all raise ALT. Sometimes stopping the medication normalises it.
  • Alcohol: Even moderate drinking can raise GGT and ALT. A period of abstinence (4–6 weeks) followed by a recheck can be diagnostic.
  • Weight/BMI: NAFLD is the most common cause of raised ALT in the UK, affecting roughly 25–30% of adults. It's strongly linked to being overweight.
  • Viral hepatitis: Hepatitis B and C blood tests should be checked if not done already.
  • Autoimmune markers: ANA, smooth muscle antibodies, immunoglobulins — checking for autoimmune hepatitis.

Step 3: When to Image the Liver

Imaging is the right next step when:

  • ALT remains elevated after addressing reversible causes (3–6 months of lifestyle changes)
  • ALT is significantly raised (>2–3x upper limit) from the start
  • You have symptoms: fatigue, right-upper-quadrant abdominal pain, jaundice, unexplained weight loss
  • Other blood markers are abnormal (raised bilirubin, low albumin, raised GGT/ALP)
  • You need to quantify fatty liver — MRI can give an exact fat percentage

Ultrasound First

The usual first-line imaging is a liver ultrasound. It can detect:

  • Fatty liver (bright/echogenic liver on ultrasound)
  • Gallstones
  • Obvious masses or cysts
  • Bile duct dilation

But ultrasound has significant limitations: it's operator-dependent, can't quantify fat precisely, struggles with deep lesions in larger patients, and can't characterise lesions as well as MRI.

Step 4: The Liver MRI

Liver MRI is indicated when ultrasound is inconclusive, when precise fat or iron quantification is needed, or when a lesion needs characterisation. Here's what MRI adds:

What MRI Measures Why It Matters Ultrasound Can Do This?
Proton density fat fraction (PDFF) Exact liver fat percentage (e.g., 18% fat) No — ultrasound can only say "fatty" or "not fatty"
Iron concentration (R2*) Detects haemochromatosis No
Lesion characterisation Benign (cyst, haemangioma) vs suspicious (HCC, metastasis) Limited
Fibrosis assessment MR elastography can estimate fibrosis stage Ultrasound elastography exists but is less accurate
Bile duct imaging (MRCP) Detailed bile duct anatomy without radiation Basic duct dilation only

Step 5: Understanding Your MRI Results

Your liver MRI report will include:

  • Liver size and shape: Enlarged (hepatomegaly) or normal.
  • Fat content: If PDFF was performed — expressed as a percentage. Normal <5%. Mild steatosis 5–17%. Moderate 17–22%. Severe >22%.
  • Iron content: Normal or overloaded (if measured).
  • Any focal lesions: Size, location, and characterisation. The radiologist will classify them (cyst, haemangioma, focal nodular hyperplasia, adenoma, or suspicious for malignancy).
  • Bile ducts: Normal calibre or dilated. Any stones or strictures visible.
  • Surrounding structures: Spleen size, portal vein patency, ascites (fluid).

Step 6: What Happens Next

  • NAFLD with mild fat (<17%) + no fibrosis: Lifestyle changes — weight loss, exercise, reduce alcohol. Repeat bloods and MRI in 12 months to track progress.
  • Significant fatty liver (>17%) or fibrosis: Referral to hepatology. More aggressive lifestyle intervention. Possible medication.
  • Benign lesion (cyst/haemangioma): Usually no treatment needed. Monitoring if large.
  • Suspicious lesion: Urgent hepatology referral. May need biopsy or further imaging.
  • Iron overload: Genetic testing for haemochromatosis. Treatment: venesection (regular blood removal).

Related Guides

At-Home Blood Testing

Check your levels from home

Professional phlebotomist visit. Doctor-reviewed results in 2-5 days. Track your health with comprehensive blood panels.

View Core Health 45 →

45-70 biomarkers tested · Venous blood draw · From £130

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.